Simultaneous assessment of NAD(P)H and flavins with multispectral fluorescence lifetime imaging microscopy at a single excitation wavelength of 750 nm.


Journal

Journal of biomedical optics
ISSN: 1560-2281
Titre abrégé: J Biomed Opt
Pays: United States
ID NLM: 9605853

Informations de publication

Date de publication:
Oct 2024
Historique:
received: 29 05 2024
revised: 26 08 2024
accepted: 06 09 2024
medline: 1 10 2024
pubmed: 1 10 2024
entrez: 1 10 2024
Statut: ppublish

Résumé

Autofluorescence characteristics of the reduced nicotinamide adenine dinucleotide and oxidized flavin cofactors are important for the evaluation of the metabolic status of the cells. The approaches that involve a detailed analysis of both spectral and time characteristics of the autofluorescence signals may provide additional insights into the biochemical processes in the cells and biological tissues and facilitate the transition of spectral fluorescence lifetime imaging into clinical applications. We present the experiments on multispectral fluorescence lifetime imaging with a detailed analysis of the fluorescence decays and spectral profiles of the reduced nicotinamide adenine dinucleotide and oxidized flavin under a single excitation wavelength aimed at understanding whether the use of multispectral detection is helpful for metabolic imaging of cancer cells. We use two-photon spectral fluorescence lifetime imaging microscopy. Starting from model solutions, we switched to cell cultures treated by metabolic inhibitors and then studied the metabolism of cells within tumor spheroids. The use of a multispectral detector in combination with an excitation at a single wavelength of 750 nm allows the identification of fluorescence signals from three components: free and bound NAD(P)H, and flavins based on the global fitting procedure. Multispectral data make it possible to assess not only the lifetime but also the spectral shifts of emission of flavins caused by chemical perturbations. Altogether, the informative parameters of the developed approach are the ratio of free and bound NAD(P)H amplitudes, the decay time of bound NAD(P)H, the amplitude of flavin fluorescence signal, the fluorescence decay time of flavins, and the spectral shift of the emission signal of flavins. Hence, with multispectral fluorescence lifetime imaging, we get five independent parameters, of which three are related to flavins. The approach to probe the metabolic state of cells in culture and spheroids using excitation at a single wavelength of 750 nm and a fluorescence time-resolved spectral detection with the consequent global analysis of the data not only simplifies image acquisition protocol but also allows to disentangle the impacts of free and bound NAD(P)H, and flavin components evaluate changes in their fluorescence parameters (emission spectra and fluorescence lifetime) upon treating cells with metabolic inhibitors and sense metabolic heterogeneity within 3D tumor spheroids.

Identifiants

pubmed: 39351138
doi: 10.1117/1.JBO.29.10.106501
pii: 240151GR
pmc: PMC11440180
doi:

Substances chimiques

NADP 53-59-8
Flavins 0
NAD 0U46U6E8UK

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106501

Informations de copyright

© 2024 The Authors.

Auteurs

Boris Yakimov (B)

Sechenov First Moscow State Medical University, Laboratory of Clinical Biophotonics, Moscow, Russia.
M.V. Lomonosov Moscow State University, Faculty of Physics, Moscow, Russia.

Anastasia Komarova (A)

Privolzhsky Research Medical University, Institute of Experimental Oncology and Biomedical Technologies, Novgorod, Russia.

Elena Nikonova (E)

Sechenov First Moscow State Medical University, Laboratory of Clinical Biophotonics, Moscow, Russia.

Artem Mozherov (A)

Privolzhsky Research Medical University, Institute of Experimental Oncology and Biomedical Technologies, Novgorod, Russia.

Liubov Shimolina (L)

Privolzhsky Research Medical University, Institute of Experimental Oncology and Biomedical Technologies, Novgorod, Russia.

Marina Shirmanova (M)

Privolzhsky Research Medical University, Institute of Experimental Oncology and Biomedical Technologies, Novgorod, Russia.

Wolfgang Becker (W)

Becker&Hickl GmbH, Berlin, Germany.

Evgeny Shirshin (E)

Sechenov First Moscow State Medical University, Laboratory of Clinical Biophotonics, Moscow, Russia.
M.V. Lomonosov Moscow State University, Faculty of Physics, Moscow, Russia.

Vladislav Shcheslavskiy (V)

Privolzhsky Research Medical University, Institute of Experimental Oncology and Biomedical Technologies, Novgorod, Russia.
Becker&Hickl GmbH, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH